Skip to main content

Scapho 150mg Injection| Secukinumab Uses & Side effects

SCAPHO 150MG

DESCRIPTION

Secukinumab is a generic form of brand name scapho 150mg and scapho 150mg injection is a type of biological therapy which prevent the function of IL-17A proteins. This activity alters the immune activity and inflammation which cause the symptoms of psoriatic arthritis.
Scapho 150mg is used as prescription drug given by a doctor rheumatologist for adults with psoriatic arthritis and ankylosing spondylitis.

INDICATION

Scapho 150mg injection prescribed for the therapy of patients with following condition :
• Plaque Psoriasis
• Psoriatic arthritis
• Ankylosing spondylitis

MECHNAISM OF ACTION

Secukinumab (Scapho 150mg injection) consist of human IgG1 monoclonal antibody whichcarefullyconnects to the interleukin-17A (IL-17A) cytokine and prohibits its concomitant with the IL-17 receptor. IL-17A is a naturally appearing cytokine included in normal inflammatory and immune responses. Secukinumab prevents the release of proinflammatory cytokines and chemokines.

PRODUCT DETAILS

Brand :Scapho
Ingredients : Secukinumab
Strength : 150mg
Manufactured : Novartis India Ltd
Package : 150mg in 1 vial
Price : scapho 150mg price in India

Scapho 150mg

Scapho 150mg


ADME

Absorption: high plasma concentration for single dose is 6 days and weekly dosing for first month is 31-34 days Distribution: volume of distribution is 7.1 – 8.6 in IV administration Metabolism: Intracellular catabolism is the drug metabolized Elimination: half-life is 22-31 days

DOSAGE MANAGEMENT

Plaque Psoriasis :
Scapho 150mg injection Initial dose for the patients is given 300 mg SC at weeks 0, 1, 2, 3, and 4
initially at week 8, given 300 mg SC once monthly
The prescribed dose for plaque psoriasis is 150 mg may be acceptable for some patients
Psoriatic Arthritis :
The recommended dosage for Psoriatic arthritis for other patients, administer with or without a loading dosage by SC injection
Scapho 150mg the recommended dose with loading dose administrated 150 mg SC at weeks 0, 1, 2, 3, and 4 and q4wk thereafter
Scapho 150mg injection the recommended dose without loading dose administrated 150 mg SC q4wk.
Dosage of 300 mgshould be taken by patient ifcontinues to have active psoriatic arthritis,
May be given with or without methotrexate.
Ankylosing Spondylitis :
The recommended dose is given with or without a loading dosage by SC injection
Scapho the recommended dose with loading dose is administrated 150 mg SC at weeks 0, 1, 2, 3, and 4 and q4wk thereafter

PRECAUTIONS

• When using Scapho 150mg injection will increased risk of infections; use with caution in patients with chronic infection or a history of recurrent infection
• Do not take vaccination of Secukinumab recipients with live virus vaccines because of probability of transmission of infection by vaccine
• When using scapho 150mg medication then Anaphylaxis and cases of urticaria resulted; if this appears, discontinue scapho 150mg injection immediately and start anaphylaxis treatment
• The treatment with Secukinumab should not be given to patients with active tuberculosis infection

Plaque Psoriasis

Plaque Psoriasis


SIDE EFFECTS

• Swelling under your skin
• Sores on your genital or anal areas
• Painful skin sores
• infections
• Nasopharyngitis
• Diarrhea
• URT infection
• Rhinitis
• Oral herpes
• Pharyngitis
• Urticaria
• Rhinorrhoea

DRUG INTERACTION

CYP450 substrates co administration with scapho 150mg injection may altered by increased levels of certain cytokines
Live vaccinations co administration with scapho 150mg should be avoided

CONTRAINDICATION

Patients having Serious hypersensitivity reactions to the active substance or to any of the excipients

PREGNANCY

Pregnancy category is B
Use the scapho 150mg injection with caution during pregnancy

LACTATION

Excretion into human milk is unknown. Use with caution while administrating Scapho 150mg injection to a nursing woman

STORAGE

Store the drug at 20°C – 80°C
Store in original carton and protect from light until the time of use

MISSED DOSE

If failed to take a dose, patients should consult with medical practitioner and follow the instructions given by them.
Or swap the missed dose and continue the regular dosing schedule.

CONTACT US 

EMAIL ID : millionhealthpharmaceuticals@gmail.com

PHONE NO : +91-9940472902

Labels:

Comments

Post a Comment

Popular posts from this blog

Xbira 250mg : Abiraterone acetate Cipla Uses, Side Effect, Price india

Drug profile of Xbira xbira 250mg tablet  are containing an active component known as Abiraterone acetate which exhibits anti-tumor activity against prostate cancer. xbira 250mg  Cipla is a derivative of androstene, which involves in the prohibition process of steroid 17 alpha hydroxylase and containing anti-neoplastic activity. Abiraterone acetate  xbira  is an oral tablet which is an active acetate ester form of steroidal compound known as Abiraterone with anti-androgenic activity. Abiraterone acetate  xbira 250mg tablet  is involved by interfering with testosterone activity by inhibiting the synthesis. PRODUCT DETAILS Brand name: Xbira Active substance: Abiraterone acetate Strength: 250mg Mfg: Cipla Pack: 120 tablets in a container Classified as: Anti-neoplastic agent Prescribing information of Xbira The most important indication of  xbira 250mg tablet   is; Metastatic castration resistance prostate cancer Metastatic high risk c...
Post a Comment
Read more

sovihep D

sovihep D Description The active substance is Sofosbuvir and Daclatasvir ( sovihep d tablet ), which is an inhibitor of the NS5A protein required for the synthesis of HCV. The main purpose of the  sovihep d  is antiviral therapy. It is active in the fight against viral hepatitis C (genotypes 1, 2, 3, 4). The essence of the impact is to block the development of HCV and its spread in the body of the carrier. HCV exists in different forms known as genotypes. Genotype 1 is the most common type of HCV genotype and  sovihep d tablet  is also the most difficult to treat using other treatments. Mechanism of Action: DCV is an HCV NS5A replication complex inhibitor. This NS5A  sovihep d  viral protein has enzymatic activity that is essential for HCV RNA replication and assembly. In replication it appears to play a role in the formation of a membranous web along with viral protein NS4B, and this web provides a platform for replication. The NS5A protein is compo...
Post a Comment
Read more

Купи Revolade 25mg| Цена Revolade 25mg продукт

REVOLADE  25мг ОПИСАНИЕ Eltrombopag се продава под търговската марка Revolade и е изкуствена форма на протеин, който увеличава производството на тромбоцити (кръвосъсирващи клетки) в тялото ви. Revolade 25мг може да намали риска от кървене чрез увеличаване на тромбоцитите в кръвта. Revolade 25мг капсулы , който се използва като лекарство за предписване под ръководството на медицинските специалисти ПОКАЗАНИЯ Revolade 25 мг е противораково лекарство, което е; Показани за лечение на пациенти с тежка апластична анемия • Първа линия на лечение на тежка апластична анемия • Лечение на рефрактерна тежка апластична анемия Посочени за лечение, за стимулиране на растежа и развитието на тромбоцити в костния мозък Показано е предимно за лечение на пациенти с намален брой тромбоцити поради хронична инфекция с вируса на хепатит С МЕХАНИЗЪМ НА ДЕЙСТВИЕ Елтромбопаг се състои от клас лекарства, известни като агонисти на тромбопоетиновите рецептори. Клас лекарства е група лекарства...
Post a Comment
Read more